Belatacept Removal by Plasmapheresis: Dose Adjustments and Clinical Recommendations

• Nicole K. Wilson, PharmD, MS, BCTXP,
• Simon Tremblay, PharmD, PhD,
• Adele R. Shields, PharmD,
• E. Steve Woodle, MD,
• Rita R. Alloway, PharmD,
• Alexander A. Vinks, PharmD, PhD,
• Bradley Miyagawa, PharmD,
• Tomoyuki Mizuno, PhD

Affiliations

Nicole K. Wilson, PharmD, MS, BCTXP

1 Department of Surgery, University of Cincinnati, Cincinnati, OH.

Simon Tremblay, PharmD, PhD

1 Department of Surgery, University of Cincinnati, Cincinnati, OH.

Adele R. Shields, PharmD

1 Department of Surgery, University of Cincinnati, Cincinnati, OH.

E. Steve Woodle, MD

1 Department of Surgery, University of Cincinnati, Cincinnati, OH.

Rita R. Alloway, PharmD

1 Department of Surgery, University of Cincinnati, Cincinnati, OH.

Alexander A. Vinks, PharmD, PhD

5 Division of Clinical Pharmacology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH.

Bradley Miyagawa, PharmD

5 Division of Clinical Pharmacology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH.

Tomoyuki Mizuno, PhD

5 Division of Clinical Pharmacology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH.